T. Rowe Price Associates’s PetMed Express PETS Stock Holding History

T. Rowe Price Associates’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$274K	Hold	120,055	–	–	﹤0.01%	2726
2025 Q4	$385K	Hold	120,055	–	–	﹤0.01%	2512
2025 Q3	$302K	Hold	120,055	–	–	﹤0.01%	2602
2025 Q2	$399K	Sell	120,055 -1,645	-1%	-$5.86K	﹤0.01%	2409
2025 Q1	$510K	Hold	121,700	–	–	﹤0.01%	2245
2024 Q4	$587K	Sell	121,700 -8,400	-6%	-$39.4K	﹤0.01%	2221
2024 Q3	$479K	Buy	130,100 +10,800	+9%	+$38.2K	﹤0.01%	2261
2024 Q2	$484K	Sell	119,300 -9,929	-8%	-$42.4K	﹤0.01%	2202
2024 Q1	$620K	Buy	129,229 +42,125	+48%	+$245K	﹤0.01%	2123
2023 Q4	$659K	Buy	87,104 +8,956	+11%	+$73.6K	﹤0.01%	2057
2023 Q3	$802K	Buy	78,148 +37,240	+91%	+$460K	﹤0.01%	1892
2023 Q2	$565K	Buy	40,908 +4,264	+12%	+$64K	﹤0.01%	2069
2023 Q1	$596K	Buy	36,644 +376	+1%	+$7.08K	﹤0.01%	2027
2022 Q4	$642K	Buy	36,268 +7,725	+27%	+$153K	﹤0.01%	2013
2022 Q3	$558K	Buy	28,543 +1,163	+4%	+$24.7K	﹤0.01%	2068
2022 Q2	$545K	Sell	27,380 -2,293	-8%	-$51.2K	﹤0.01%	2192
2022 Q1	$766K	Sell	29,673 -12,880	-30%	-$334K	﹤0.01%	2136
2021 Q4	$1.07M	Buy	42,553 +24,057	+130%	+$666K	﹤0.01%	2003
2021 Q3	$497K	Buy	18,496 +315	+2%	+$9.07K	﹤0.01%	2387
2021 Q2	$579K	Sell	18,181 -6,998	-28%	-$222K	﹤0.01%	2323
2021 Q1	$886K	Sell	25,179 -7,883	-24%	-$274K	﹤0.01%	2113
2020 Q4	$1.06M	Sell	33,062 -6,100	-16%	-$188K	﹤0.01%	1914
2020 Q3	$1.24M	Buy	39,162 +9,600	+32%	+$318K	﹤0.01%	1717
2020 Q2	$1.05M	Buy	29,562 +3,644	+14%	+$127K	﹤0.01%	1765
2020 Q1	$746K	Sell	25,918 -4,756	-16%	-$125K	﹤0.01%	1823
2019 Q4	$721K	Buy	30,674 +10,266	+50%	+$230K	﹤0.01%	2019
2019 Q3	$368K	Buy	20,408 +340	+2%	+$5.61K	﹤0.01%	2211
2019 Q2	$314K	Buy	20,068 +38	+0.2%	+$748	﹤0.01%	2287
2019 Q1	$456K	Buy	20,030 +420	+2%	+$9.47K	﹤0.01%	2148
2018 Q4	$456K	Sell	19,610 -3,565	-15%	-$95.2K	﹤0.01%	2109
2018 Q3	$765K	Sell	23,175 -80	-0.3%	-$2.99K	﹤0.01%	1977
2018 Q2	$1.02M	Buy	23,255 +8,491	+58%	+$329K	﹤0.01%	1827
2018 Q1	$616K	Sell	14,764 -2,721	-16%	-$126K	﹤0.01%	2003
2017 Q4	$796K	Buy	17,485 +830	+5%	+$32.7K	﹤0.01%	1895
2017 Q3	$552K	Sell	16,655 -7	-0%	-$285	﹤0.01%	2055
2017 Q2	$676K	Hold	16,662	–	–	﹤0.01%	1945
2017 Q1	$336K	Hold	16,662	–	–	﹤0.01%	2206
2016 Q4	$384K	Hold	16,662	–	–	﹤0.01%	2160
2016 Q3	$338K	Hold	16,662	–	–	﹤0.01%	2170
2016 Q2	$313K	Sell	16,662 -38	-0.2%	-$698	﹤0.01%	2149
2016 Q1	$299K	Buy	16,700 +4,000	+31%	+$68.5K	﹤0.01%	2155
2015 Q4	$218K	Buy	12,700 +100	+0.8%	+$1.68K	﹤0.01%	2278
2015 Q3	$203K	Hold	12,600	–	–	﹤0.01%	2286
2015 Q2	$218K	Hold	12,600	–	–	﹤0.01%	2316
2015 Q1	$208K	Hold	12,600	–	–	﹤0.01%	2338
2014 Q4	$181K	Hold	12,600	–	–	﹤0.01%	2378
2014 Q3	$171K	Hold	12,600	–	–	﹤0.01%	2381
2014 Q2	$170K	Hold	12,600	–	–	﹤0.01%	2394
2014 Q1	$169K	Hold	12,600	–	–	﹤0.01%	2363
2013 Q4	$210K	Hold	12,600	–	–	﹤0.01%	2296
2013 Q3	$205K	Hold	12,600	–	–	﹤0.01%	2261
2013 Q2	$159K	Buy	+12,600	New	+$164K	﹤0.01%	2255

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SPH

Steel Partners Holdings New York $96.4M AUM

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

T. Rowe Price Associates's PETS Position: Q1 2026 in Review

T. Rowe Price Associates held its PetMed Express (PETS) position steady in Q1 2026 at 120,055 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

T. Rowe Price Associates first reported a position in PETS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.24M in Q3 2020. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

T. Rowe Price Associates held 120,055 shares of PetMed Express worth $274K as of Q1 2026.
T. Rowe Price Associates left its PetMed Express share count unchanged in Q1 2026.
PetMed Express made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2726 holding.
T. Rowe Price Associates first reported a position in PetMed Express in Q2 2013 and has held it in 52 quarters since.
T. Rowe Price Associates's PetMed Express position peaked at $1.24M in Q3 2020.
49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.